spacer
home > epc > Spring 2018
PUBLICATIONS

European Pharmaceutical Contractor

epc
Spring 2018

   
Text
PDF
bullet
Clinical Laboratories & Logistics
Q&A: Clinical Finances

Money Matters

The many financial aspects that must be considered within a clinical trial and the role that a CRO plays in the process are explored by Greenphire’s Dave Espenshade.
 
view
download pdf
Patient Centricity

A Winning Formula

To fully realise commercialisation and drug development, patient centricity is an important factor to consider. Justin Schroeder at PCI Pharma Services demonstrates how this can help a patient-focused approach excel.
 
view
download pdf
Early Phase Development

Early Beginnings

Dr Torkel Gren at Recipharm Pharmaceutical Development and Anders Millerhovf at CTC Clinical Trial Consultants examine an integrated approach to early phase trials that will ensure new drugs are effectively and securely produced.
 
view
download pdf
Content Management

Data Diligence

Pharmaceutical companies need to gather data from busy healthcare professionals, and they should pay attention to how to do this and the ways in which it can be used to develop supply and logistics, says Kieran Bourke at MAXX Design.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

PCI Pharma Services Announces Agreement to Acquire Sherpa Clinical Packaging

Philadelphia, USA – September 10, 2018 Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce the acquisition of San Diego-based Sherpa Clinical Packaging (Sherpa), which expands PCI’s U.S. operations to the West Coast. The acquisition of Sherpa, a provider of clinical trial supply services, further strengthens PCI’s position as a leader in outsourced clinical trial support services. The addition of Sherpa’s capabilities also enables PCI to better support customers from early phases of clinical development through to commercial launch.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

Industry Events

Pre-Filled Syringes & Injectable Drug Devices Europe

16-17 January 2019, Copthorne Tara Hotel, London

SMi is proud to present their 11th annual European conference and exhibition, within the Pre-Filled Syringes series: Pre-Filled Syringes & Injectable Drug Devices Europe. The event will take place on the 16th-17th of January 2019, in London.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement